Bristol Myers Squibb Performance

The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Bristol-Myers Squibb are completely uncorrelated.

Risk-Adjusted Performance

0 of 100

Very Weak
Over the last 90 days Bristol Myers Squibb has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable primary indicators, Bristol-Myers Squibb is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors. ...more
Begin Period Cash Flow15 B
Total Cashflows From Investing Activities-538 M

Bristol-Myers Squibb Relative Risk vs. Return Landscape

If you would invest (100.00) in Bristol Myers Squibb on January 16, 2024 and sell it today you would earn a total of  100.00  from holding Bristol Myers Squibb or generate -100.0% return on investment over 90 days. Bristol Myers Squibb is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Bristol-Myers, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   

Bristol-Myers Squibb Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Bristol-Myers Squibb's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Bristol Myers Squibb, and traders can use it to determine the average amount a Bristol-Myers Squibb's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Based on monthly moving average Bristol-Myers Squibb is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bristol-Myers Squibb by adding Bristol-Myers Squibb to a well-diversified portfolio.

Bristol-Myers Squibb Fundamentals Growth

Bristol-Myers Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Bristol-Myers Squibb, and Bristol-Myers Squibb fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bristol-Myers Pink Sheet performance.

Things to note about Bristol Myers Squibb performance evaluation

Checking the ongoing alerts about Bristol-Myers Squibb for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Bristol Myers Squibb help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Bristol Myers Squibb is not yet fully synchronised with the market data
Bristol Myers Squibb has some characteristics of a very speculative penny stock
Bristol Myers Squibb has a very high chance of going through financial distress in the upcoming years
Evaluating Bristol-Myers Squibb's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Bristol-Myers Squibb's pink sheet performance include:
  • Analyzing Bristol-Myers Squibb's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bristol-Myers Squibb's stock is overvalued or undervalued compared to its peers.
  • Examining Bristol-Myers Squibb's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Bristol-Myers Squibb's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bristol-Myers Squibb's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Bristol-Myers Squibb's pink sheet. These opinions can provide insight into Bristol-Myers Squibb's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Bristol-Myers Squibb's pink sheet performance is not an exact science, and many factors can impact Bristol-Myers Squibb's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Bristol-Myers Pink Sheet

If you are still planning to invest in Bristol Myers Squibb check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bristol-Myers Squibb's history and understand the potential risks before investing.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Bonds Directory
Find actively traded corporate debentures issued by US companies
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm